<?xml version="1.0" encoding="UTF-8"?>
<ref id="B79">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Reynolds</surname>
    <given-names>H. R.</given-names>
   </name>
   <name>
    <surname>Adhikari</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Pulgarin</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Troxel</surname>
    <given-names>A. B.</given-names>
   </name>
   <name>
    <surname>Iturrate</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Johnson</surname>
    <given-names>S. B.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2020</year>). 
  <article-title>Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19</article-title>. 
  <source>N. Engl. J. Med.</source>
  <volume>382</volume> (
  <issue>25</issue>), 
  <fpage>2441</fpage>–
  <lpage>2448</lpage>.  
  <pub-id pub-id-type="doi">10.1056/NEJMoa2008975</pub-id>
  <pub-id pub-id-type="pmid">32356628</pub-id>
 </mixed-citation>
</ref>
